X-LAG: How did they grow so tall?

Ann Endocrinol (Paris). 2017 Jun;78(2):131-136. doi: 10.1016/j.ando.2017.04.013. Epub 2017 Apr 27.

Abstract

X-linked acrogigantism (XLAG) is a new, pediatric-onset genetic syndrome, due to Xq26.3 microduplications encompassing the GPR101 gene. XLAG has a remarkably distinct phenotype with disease onset occurring before the age of 5 in all cases described to date, which is significantly younger than in other forms of pituitary gigantism. These patients have mixed GH and prolactin positive adenomas and/or mixed-cell hyperplasia and highly elevated levels of GH/IGF-1 and prolactin. Given their particularly young age of onset, the significant GH hypersecretion can lead to a phenotype of severe gigantism with very advanced age-specific height Z-scores. If not adequately treated in childhood, this condition results in extreme final adult height. XLAG has a clinical course that is highly similar to some of the tallest people with gigantism in history.

Keywords: Familial isolated pituitary adenoma (FIPA); GPR101 gene; Gigantism; Le gigantisme; Le gène GPR101; L’acro-gigantisme lié au chromosome X (X-LAG); L’adénome hypophysaire; L’adénome hypophysaire familial isolé (FIPA); Pituitary adenoma; X-linked acrogigantism (X-LAG).

Publication types

  • Historical Article
  • Review

MeSH terms

  • Age of Onset
  • Female
  • Gene Duplication
  • Gigantism / genetics*
  • Gigantism / history
  • Gigantism / pathology
  • History, 19th Century
  • History, 20th Century
  • Humans
  • Male
  • Pituitary Hormones / blood
  • Prolactinoma / genetics
  • Prolactinoma / pathology
  • Receptors, G-Protein-Coupled / genetics

Substances

  • GPR101 protein, human
  • Pituitary Hormones
  • Receptors, G-Protein-Coupled